(Q24241789)

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

High-dose estradiol improves cognition for women with AD: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

The role of estrogen in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Senile dementia-Alzheimer's type and estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

No additional benefit of HRT on response to rivastigmine in menopausal women with AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Postmenopausal estrogen and prevention bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Ageing, cognition and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Hormone replacement therapy and cognition: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Hormone replacement therapy for cognitive function in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Ovarian steroids and the brain: implications for cognition and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Memory functioning at menopause: impact of age in ovariectomized women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Hormone replacement therapy and stroke: risk, protection or no effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Thiamine for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Estrogen and the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Estrogen as a treatment for Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Cognitive decline in women in relation to non-protein-bound oestradiol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Hormone replacement therapy to maintain cognitive function in women with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003799.PUB2

Should surgical menopausal women be treated with estrogens to decrease the risk of dementia?

21 January 2018

1 reference

12 December 2020

An evaluation of psychologic effects of sex hormone administration in aged women. I. Results of therapy after six months

1 reference

12 December 2020

Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

1 reference

12 December 2020

The Women’s Health Initiative Memory Study (WHIMS)

1 reference

12 December 2020

Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type

1 reference

12 December 2020

Reduced plasma oestrogen stimulated neurophysin and delayed response to oestrogen challenge in Alzheimer's disease.

1 reference

12 December 2020

Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports.

1 reference

12 December 2020

Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women.

1 reference

12 December 2020

Menopausal hormone therapy in a health maintenance organization before and after women's health initiative hormone trials termination

1 reference

12 December 2020

10.1002/14651858.CD003799.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

264304

OpenCitations bibliographic resource ID

264304

1 reference